Danaher Stock Forecast for 2022 - 2025 - 2030

Updated on 05/24/2022

Stock Rating
5 / 10
Price Target
$335.00
Consensus
Outperform
Upside
32.94%
Analysts
7
Stock Rating
5
Upside
32.94%
Analysts
7
Price Target
$335.00

The average target price for Danaher's stock set by seven renowned analysts in recent months is $335.00, representing a potential upside of approximately 32.94% from its last closing price if met by 2023. This estimation is based on a high estimate of $375.00 and a low estimate of $200.00. Although you may not be interested in DHR stock, you should still be aware of its competitors.

$335.00

32.94% Upside

Outperform
Outperform

Danaher Fair Value Forecast for 2022 - 2025 - 2030

In the last three years, Danaher's Fair Value has seen significant growth, surging from $136.32 to $303.11 – an increase of 122.35%. In the next year, analysts predict that Fair Value will jump to $313.97 – up 3.58% from the current level. Looking ahead to nine years, experts forecast that Fair Value will grow by 127.36%.

2022 Fair Value Forecast
$313.97
2023 Fair Value Forecast
$329.35
2024 Fair Value Forecast
$362.52
2025 Fair Value Forecast
$402.33
2026 Fair Value Forecast
$434.00
2027 Fair Value Forecast
$507.59
2028 Fair Value Forecast
$561.23
2029 Fair Value Forecast
$619.90
2030 Fair Value Forecast
$689.16
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
AVGO Stock Forecast Broadcom Outperform 7
$524.20 $687.47 33.54% 25
ABT Stock Forecast Abbott Laboratories Outperform 7
$113.77 $141.24 23.06% 19
BMY Stock Forecast Bristol-Myers Squibb Outperform 8
$77.13 $76.69 1.13% 16
AMGN Stock Forecast Amgen Hold 6
$251.89 $246.46 -0.75% 13
MMM Stock Forecast 3M Hold 5
$145.75 $188.41 9.98% 17

Danaher Revenue Forecast for 2022 - 2025 - 2030

In the last three years, Danaher's Revenue has seen significant growth, surging from $17.05B to $29.45B – an increase of 72.76%. In the next year, analysts predict that Revenue will jump to $30.82B – up 4.65% from the current level. Looking ahead to nine years, experts forecast that Revenue will grow by 79.83%.

2022 Rev Forecast
$30.82B
2023 Rev Forecast
$32.27B
2024 Rev Forecast
$34.95B
2025 Rev Forecast
$38.32B
2026 Rev Forecast
$40.63B
2027 Rev Forecast
$43.63B
2028 Rev Forecast
$46.73B
2029 Rev Forecast
$49.73B
2030 Rev Forecast
$52.97B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
GE Stock Forecast General Electric Outperform 2
$74.52 $121.44 43.59% 13
BDX Stock Forecast Becton, Dickinson and Outperform 5
$257.45 $270.20 10.7% 3
BAYN Stock Forecast Bayer Outperform 5
63.29€ 67.79€ 20.08% 14

Danaher Dividend per Share Forecast for 2022 - 2025 - 2030

In the past three years, Danaher's DPS has seen a relatively significant increase, rising from $0.64 to $0.84. This represents a growth of 31.25%. Analysts predict that Danaher's DPS will increase moderately in the upcoming year, reaching $1.05. This would represent an increase of 25%. Over the next nine years, experts predict that Danaher's DPS will grow at a rate of 252.77%

2022 DPS Forecast
$1.05
2023 DPS Forecast
$1.12
2024 DPS Forecast
$1.28
2025 DPS Forecast
$1.61
2026 DPS Forecast
$1.80
2027 DPS Forecast
$2.06
2028 DPS Forecast
$2.36
2029 DPS Forecast
$2.65
2030 DPS Forecast
$2.96
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
EW Stock Forecast Edwards Lifesciences Outperform 5
$94.54 $127.85 37.51% 19
BSX Stock Forecast Boston Scientific Outperform 4
$40.15 $49.85 24.53% 23
ETN Stock Forecast Eaton Outperform 4
$133.83 $182.50 30.76% 20

Danaher Free Cash Flow Forecast for 2022 - 2025 - 2030

In three years, Free Cash Flow for Danaher has grown by a whopping 109.84%, going from $3.37B to $7.06B. In the coming year, analysts are expecting a small increase in Free Cash Flow, predicting it will reach $7.55B – an increase of 6.92%. Over the next nine years, experts anticipate that Free Cash Flow growth for Danaher will be 128.14%.

2022 FCF Forecast
$7.55B
2023 FCF Forecast
$8.05B
2024 FCF Forecast
$9.12B
2025 FCF Forecast
$11.08B
2026 FCF Forecast
$9.86B
2027 FCF Forecast
$11.24B
2028 FCF Forecast
$12.82B
2029 FCF Forecast
$14.41B
2030 FCF Forecast
$16.12B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
F Stock Forecast Ford Motor Hold 6
$12.42 $21.82 44.93% 16
EMR Stock Forecast Emerson Electric Outperform 4
$83.89 $110.43 31.12% 10
DOW Stock Forecast Dow Outperform 3
$67.07 $64.10 10.33% 11

Danaher Net Income Forecast for 2022 - 2025 - 2030

Danaher's Net Income has seen astonishing growth in the last three years, going from $2.65B to $6.43B – a gain of 142.67% In the next year, analysts believe that Net Income will reach a reasonable $7.70B – an increase of 19.74% For the next nine years, the forecast is for Net Income to grow by 99.85%

2022 NI Forecast
$7.70B
2023 NI Forecast
$8.05B
2024 NI Forecast
$8.83B
2025 NI Forecast
$9.32B
2026 NI Forecast
$10.01B
2027 NI Forecast
$10.71B
2028 NI Forecast
$11.38B
2029 NI Forecast
$12.11B
2030 NI Forecast
$12.86B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
6501 Stock Forecast Hitachi Buy 4
¥6.40k ¥0.00 24.98% 0
ECL Stock Forecast Ecolab Outperform 4
$158.40 $204.59 21.84% 10
A Stock Forecast Agilent Technologies Outperform 7
$124.41 $172.40 28.61% 2

Danaher EBITDA Forecast for 2022 - 2025 - 2030

Danaher's EBITDA has seen major growth over the last three years, jumping from $4.27B to $10.34B – an increase of 142.21%. In the next year, analysts predict that EBITDA will reach an unimpressive $10.68B – an increase of 3.37%. For the next nine years, the forecast is for EBITDA to grow by 71.04%

2022 EBITDA Forecast
$10.68B
2023 EBITDA Forecast
$11.18B
2024 EBITDA Forecast
$12.25B
2025 EBITDA Forecast
$13.83B
2026 EBITDA Forecast
$13.13B
2027 EBITDA Forecast
$14.24B
2028 EBITDA Forecast
$15.41B
2029 EBITDA Forecast
$16.48B
2030 EBITDA Forecast
$17.68B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
BIIB Stock Forecast Biogen Outperform 4
$202.54 $287.21 12.32% 24
GLW Stock Forecast Corning Outperform 5
$33.27 $47.92 32.25% 3
CERN Stock Forecast Cerner Hold 6
$94.44 $93.31 0.59% 3

Danaher EBIT Forecast for 2022 - 2025 - 2030

Over the last three years, Danaher's EBIT has increased by 164.37%, going from $3.09B to $8.17B. In the next year, analysts are expecting a small increase in EPS, predicting it will reach $8.30B – an increase of 1.63%. The 2030 forecast is for EBIT to reach $13.28B or grow by 62.58%.

2022 EBIT Forecast
$8.30B
2023 EBIT Forecast
$8.73B
2024 EBIT Forecast
$9.61B
2025 EBIT Forecast
$10.64B
2026 EBIT Forecast
$10.75B
2027 EBIT Forecast
$11.46B
2028 EBIT Forecast
$12.11B
2029 EBIT Forecast
$12.62B
2030 EBIT Forecast
$13.28B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
AME Stock Forecast AMETEK Buy 4
$118.49 $164.02 32.5% 12
HOLX Stock Forecast Hologic Outperform 2
$78.39 $78.91 0.78% 12
DOV Stock Forecast Dover Outperform 6
$130.85 $175.77 29.16% 9

Danaher EPS Price Prediction Forecast for 2022 - 2025 - 2030

In the last three years, Danaher's EPS has seen significant growth, surging from $4.52 to $10.05 – an increase of 122.35%. In the next year, analysts predict that EPS will jump to $10.41 – up 3.58% from the current level. Looking ahead to nine years, experts forecast that EPS will grow by 127.36%.

2022 EPS Forecast
$10.41
2023 EPS Forecast
$10.92
2024 EPS Forecast
$12.02
2025 EPS Forecast
$13.34
2026 EPS Forecast
$14.39
2027 EPS Forecast
$16.83
2028 EPS Forecast
$18.61
2029 EPS Forecast
$20.55
2030 EPS Forecast
$22.85
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside Analysts
ERF Stock Forecast Eurofins Scientific Hold 2
86.95€ 0.00€ 20.76% 10
FME Stock Forecast Fresenius Medical Care AG & Co... Hold 4
56.30€ 80.66€ 16% 11
BIO Stock Forecast Bio-Rad Laboratories Outperform 7
$518.73 $701.33 34.94% 2

© Copyright 2022 | Stock Forecast | All Rights Reserved